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Introduction
Biologics started a new era in treatment of different
aspects of rheumatic disases. Authors present the effects
of anti-TNF therapy on ophtalmological complications
in their patients with juvenile idiopathic artritis (JIA),
juvenile dermatomiositis (JDM) and sarcoidosis.
Objectives
To investigate therapeutical sucess of anti-TNF therapy
on ophtalmological complications in children with rheu-
matic diseases.
Methods
Retrospective chart rewiev of all rheumatic patients with
ophtalmological complications treated with anti-TNF
therapy at Division of Paediatric Rheumatology and
Immunology, University Hospital Centre Zagreb, during
2009. – 2013. period.
Results
Among 54 children treated with anti-TNF therapy at
our Division during 2009. – 2013. period, 10 were
detected with ophtalmologycal complications (8 girls,
2 boys), 8 with JIA, 1 with JDM and 1 with sarcoidosis.
Nine patients had chronic uveitis (JIA, sarcoidosis) and
1 had …cotton wool“ retinal lesions accompanied with
bilateral papilar oedema (JDM). Avarage time between
the begining of disease and start of anti-TNF therapy
was 2.9 years (28 days – 9 years). Initial anti-TNF ther-
apy was adalimumab in 5 cases (4 JIA, 1 sarcoidosis),
etanercept in 4 cases (JIA) and infliximab in 1 case
(JDM). During therapy, etanercept was changed to adalimu-
mab in 2 cases, due to inefficacy on uveitis. Adalimumab
was partially effective in 1 case (sarcoidosis). Infliximab,
applied in patient with JDM and …cotton wool“ retinal
lesions accompanied with bilateral papilar oedema, led to
fast and complete recovery of eye changes and other
aspects of the disease.
Conclusion
Anti-TNF therapy was successfull in 90 % of our cases. To
our opinion, anti-TNF therapy should be early introduced
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